INTERACTION BETWEEN GLYCOSAMINOGLYCANS, PLATELETS, AND LEUKOCYTES

被引：25

作者：

CERLETTI, C ^{[1
]}

RAJTAR, G ^{[1
]}

MARCHI, E ^{[1
]}

DEGAETANO, G ^{[1
]}

机构：

[1] ALFA WASSERMANN FARMACEUT, BOLOGNA, ITALY

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1994年 / 20卷 / 03期

关键词：

D O I：

10.1055/s-2007-1001909

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：245 / 253

页数：9

共 56 条

[1] INFLUENCE OF TYPE OF SULFATE BOND AND DEGREE OF SULFATION OF GLYCOSAMINOGLYCANS ON THEIR INTERACTION WITH LYSOSOMAL ENZYMES [J].

AVILA, JL .

BIOCHEMICAL JOURNAL, 1978, 171 (02) :489-491

[2] INHIBITION OF HUMAN ELASTASE FROM POLYMORPHONUCLEAR LEUKOCYTES BY A GLYCOSAMINOGLYCAN POLYSULFATE (ARTEPARON) [J].

BAICI, A ;

SALGAM, P ;

FEHR, K ;

BONI, A .

BIOCHEMICAL PHARMACOLOGY, 1980, 29 (12) :1723-1727

[3]

BARBANTI M, 1993, THROMB HAEMOSTASIS, V69, P147

[4] COMPARISON OF THE PLATELET PRO-AGGREGATORY EFFECT OF CONVENTIONAL UNFRACTIONATED HEPARINS AND A LOW-MOLECULAR-WEIGHT HEPARIN FRACTION (CY-222) [J].

BARRADAS, MA ;

MIKHAILIDIS, DP ;

EPEMOLU, O ;

JEREMY, JY ;

FONSECA, V ;

DANDONA, P .

BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (04) :451-457

[5]

BAZZONI G, 1993, J LAB CLIN MED, V121, P268

[6] THROMBOCYTOPENIA OCCURRING DURING ADMINISTRATION OF HEPARIN - PROSPECTIVE-STUDY IN 52 PATIENTS [J].

BELL, WR ;

TOMASULO, PA ;

ALVING, BM ;

DUFFY, TP .

ANNALS OF INTERNAL MEDICINE, 1976, 85 (02) :155-160

[7]

BERTELE V, 1983, THROMB HAEMOSTASIS, V49, P81

[8]

BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P51

[9]

BYKOWSKA K, 1983, THROMB HAEMOSTASIS, V50, P768

[10] STRUCTURE AND BIOLOGICAL-ACTIVITY OF HEPARIN [J].

CASU, B .

ADVANCES IN CARBOHYDRATE CHEMISTRY AND BIOCHEMISTRY, 1985, 43 :51-134

← 1 2 3 4 5 6 →